SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-19-002057
Filing Date
2019-02-07
Accepted
2019-02-07 16:31:13
Documents
40
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q s115884_10q.htm 10-Q 525935
2 EXHIBIT 31.1 s115884_ex31-1.htm EX-31.1 10130
3 EXHIBIT 31.2 s115884_ex31-2.htm EX-31.2 10238
4 EXHIBIT 32.1 s115884_ex32-1.htm EX-32.1 8463
5 GRAPHIC img001_v1.jpg GRAPHIC 41698
6 GRAPHIC img002_v1.jpg GRAPHIC 33746
  Complete submission text file 0001615774-19-002057.txt   2664238

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE avxl-20181231.xml EX-101.INS 528053
8 XBRL SCHEMA FILE avxl-20181231.xsd EX-101.SCH 29938
9 XBRL CALCULATION FILE avxl-20181231_cal.xml EX-101.CAL 23951
10 XBRL DEFINITION FILE avxl-20181231_def.xml EX-101.DEF 94268
11 XBRL LABEL FILE avxl-20181231_lab.xml EX-101.LAB 228609
12 XBRL PRESENTATION FILE avxl-20181231_pre.xml EX-101.PRE 141644
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 19575553
SIC: 8731 Services-Commercial Physical & Biological Research